Ropes & Gray LLP advises life sciences and healthcare clients at every stage of the development lifecycle, with a practice spanning transactional, regulatory, IP, and enforcement matters. The firm assists clients in developing, protecting, and commercialising IP assets, advising on portfolio development, patent due diligence, freedom-to-operate assessments, and complex licensing and technology transfer arrangements. The team’s life sciences capabilities are supported by a strong corporate and commercial platform as well as an established regulatory practice. Michael Beauvais represents pharmaceutical, biotech, medical device, digital health, and healthcare services clients. Gregory Levine bolsters the team’s experience as an expert in navigating FDA challenges. Former practice co-head Kellie Combs left the firm in April 2026.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Lawyer & team quality
Testimonials
Collated independently by Legal 500 research team.
‘The life sciences regulatory and compliance practice group at Ropes & Gray has been an amazing team to work with.'
'They possess exceptional knowledge of the current regulatory landscape and have been paramount in navigating the changes that are occurring with respect to the FDA's views of drug advertising and promotion.'
'They are always available for discussions of all things FDA and OPDP, as well as provide advice on how to apply knowledge of the current landscape to our own promotional pieces.’
Lawyers
Hall of Fame
The lawyers at the very top of the profession, widely known and respected by peers and clients for their longstanding involvement in market-leading work.
Practice head
Michael Beauvais
Other key lawyers
Gregory Levine